Register
Medicines reference
Product

Omnic Ocas

Tamsulosin · Astellas Pharma Europe

1 form: modified release (retard / SR). No registration in force in Georgia.

Forms and doses0 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Used for: Functional urethral obstruction

Form Species Dose Frequency Georgia
0.4 mg, Modified release (retard / SR) · Cat Cat No dose for this species
No cat dose: no consensus or label gives a feline tamsulosin dose. Modified-release: give whole, do not open, crush or split.
- Georgia Expired
Expired on 02 Sep 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ომნიკი ოკასი 0.4მგ კონტროლირებადი გამოთავისუფლების აბი
№ რ-018169; რ-018170
Verified on: 29 Oct 2026
0.4 mg, Modified release (retard / SR) · Dog Dog 0.4–0.8 mg per animal
Off-label substance bridge: a human Tamsulosin product; dose from Core tamsulosin (ACVIM consensus 2024), same substance and route. Modified-release: give whole, do not open, crush or split. Functional urethral obstruction: 0.4-0.8 mg per dog = 1-2 whole 0.4 mg units; watch for hypotension.
· once daily
once daily Georgia Expired
Expired on 02 Sep 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ომნიკი ოკასი 0.4მგ კონტროლირებადი გამოთავისუფლების აბი
№ რ-018169; რ-018170
Verified on: 29 Oct 2026
Details: pack, label wording, sources, registration

Omnic Ocas 0.4 mg, Modified release (retard / SR)

prolonged-release tablet, human medicine
Composition / strength
Tamsulosin0.4 mg
Formulation Type
Modified release (retard / SR)
Administration route
By mouth
Registration
Georgia Expired
Expired on 02 Sep 2021, not renewed yet
Human (Ministry of Health, RAMA)
In the register: ომნიკი ოკასი 0.4მგ კონტროლირებადი გამოთავისუფლების აბი
№ რ-018169; რ-018170
Verified on: 29 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
No dose for this species
No cat dose: no consensus or label gives a feline tamsulosin dose. Modified-release: give whole, do not open, crush or split.
Cat Any weight By mouth -
ACVIM urinary incontinence
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
Journal of Veterinary Internal Medicine, 2024
0.4–0.8 mg per animal
Off-label substance bridge: a human Tamsulosin product; dose from Core tamsulosin (ACVIM consensus 2024), same substance and route. Modified-release: give whole, do not open, crush or split. Functional urethral obstruction: 0.4-0.8 mg per dog = 1-2 whole 0.4 mg units; watch for hypotension.
Dog Any weight By mouth once daily
ACVIM urinary incontinence
Guideline or consensus statement
Recommendations agreed by a panel of veterinary specialists after reviewing the evidence. They guide practice and do not authorise a product.
ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
Journal of Veterinary Internal Medicine, 2024
From the active substance's dose: the label does not cover this species; off-label for this pack.

Known Contraindications

  • Warning
    Alpha-1 blocker: hypotension can occur. The 0.4 mg modified-release capsules and tablets must be given whole: do not open, crush or split them.
    Sources: ACVIM
  • Warning
    Alpha-1 blocker: hypotension can occur. The 0.4 mg modified-release capsules and tablets must be given whole: do not open, crush or split them.
    Sources: ACVIM

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.